Acino receives Frost & Sullivan Award for Enabling Technology Leadership
Thursday 6th November 2014
Acino is proud to be the recipient of the Frost & Sullivan “2014 European Pharmaceutical Drug Delivery Enabling Technology Leadership Award”.
Frost & Sullivan, a global consulting and market research firm, presents this award to the company that has achieved technology excellence and visionary innovation. Acino is being recognized for its innovative, cutting-edge technology portfolio, pioneering best practices and delivering excellence in the pharmaceutical drug delivery space. In addition, the analysts of Frost & Sullivan emphasized the diversity of drug delivery systems, excellent product and service value, exceptional customer experience and Acino’s contribution to better therapeutic efficacy and patient compliance.
Commenting on Acino strengths and prospects, Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram said: “Its technology expertise and innovation have set it apart in the industry and will allow Acino to further expand on its market share.”
“The award honors our innovation and we appreciate this recognition of our leadership in advanced drug delivery. Our approach to product development anticipates market trends and we plan to further expand our geographic reach, especially in the emerging markets, with innovative and Swiss quality pharmaceuticals.”
Jostein Davidsen, CEO Acino
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development.